RAÚL
ORTIZ QUESADA
PROFESOR TITULAR DE UNIVERSIDAD
Publikationen, an denen er mitarbeitet PABLO ALVAREZ ARANEGA (27)
2018
-
Latest in Vitro and in Vivo Assay, Clinical Trials and Patents in Cancer Treatment using Curcumin: A Literature Review
Nutrition and Cancer, Vol. 70, Núm. 4, pp. 569-578
2017
-
Gastrointestinal stromal tumours: An actualized overview
European Journal of Anatomy, Vol. 21, Núm. 2, pp. 97-112
2015
-
Microenvironmental modulation of decorin and lumican in temozolomide-resistant glioblastoma and neuroblastoma cancer stem-like cells
PLoS ONE, Vol. 10, Núm. 7
-
Poly(butylcyanoacrylate) and Poly(ε-caprolactone) Nanoparticles Loaded with 5-Fluorouracil Increase the Cytotoxic Effect of the Drug in Experimental Colon Cancer
AAPS Journal, Vol. 17, Núm. 4, pp. 918-929
2014
-
Application of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: Review of recent patents
Recent Patents on Anti-Cancer Drug Discovery, Vol. 9, Núm. 1, pp. 21-34
-
Prognostic impact of MGMT promoter methylation and MGMT and CD133 expression in colorectal adenocarcinoma
BMC Cancer, Vol. 14, Núm. 1
-
Qualitative and quantitative analyses of anatomists' research: Evaluation of multidisciplinarity and trends in scientific production
Scientometrics, Vol. 98, Núm. 1, pp. 447-456
-
Transcriptional Profiling of Peripheral Blood in Pancreatic Adenocarcinoma Patients Identifies Diagnostic Biomarkers
Digestive Diseases and Sciences, Vol. 59, Núm. 11, pp. 2714-2720
2013
-
Antitumor properties of natural compounds and related molecules
Recent Patents on Anti-Cancer Drug Discovery, Vol. 8, Núm. 3, pp. 203-215
-
Colon cancer therapy: Recent developments in nanomedicine to improve the efficacy of conventional chemotherapeutic drugs
Anti-Cancer Agents in Medicinal Chemistry, Vol. 13, Núm. 8, pp. 1204-1216
-
Modulation of multidrug resistance gene expression in peripheral blood mononuclear cells of lung cancer patients and evaluation of their clinical significance
Cancer Chemotherapy and Pharmacology, Vol. 71, Núm. 2, pp. 537-541
-
RNA interference in the treatment of colon cancer
BioDrugs, Vol. 27, Núm. 4, pp. 317-327
-
Regulatory systems in bone marrow for hematopoietic stem/progenitor cells mobilization and homing
BioMed Research International, Vol. 2013
2012
-
5-fluorouracil-loaded poly(ε-caprolactone) nanoparticles combined with phage E gene therapy as a new strategy against colon cancer
International Journal of Nanomedicine, Vol. 7, pp. 95-107
-
Development and morphogenesis of human wrist joint during embryonic and early fetal period
Journal of Anatomy, Vol. 220, Núm. 6, pp. 580-590
-
Doxorubicin-loaded nanoparticles: New advances in breast cancer therapy
Anti-Cancer Agents in Medicinal Chemistry, Vol. 12, Núm. 9, pp. 1058-1070
-
Gef gene therapy enhances the therapeutic efficacy of cytotoxics in colon cancer cells
Biomedicine and Pharmacotherapy, Vol. 66, Núm. 7, pp. 563-567
-
How is gene transfection able to improve current chemotherapy? The role of combined therapy in cancer treatment
Current Medicinal Chemistry, Vol. 19, Núm. 12, pp. 1870-1888
-
MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
Journal of Translational Medicine, Vol. 10, Núm. 1
-
Modulation of MDR1 and MRP3 gene expression in lung cancer cells after paclitaxel and carboplatin exposure
International Journal of Molecular Sciences, Vol. 13, Núm. 12, pp. 16624-16635